UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000012813 |
|---|---|
| Receipt number | R000014967 |
| Scientific Title | Phase II trial as new adjuvant chemotherapy regimen for capecitabine in stage II and III colorectal cancer. |
| Date of disclosure of the study information | 2014/01/20 |
| Last modified on | 2019/01/18 16:47:34 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/01/10 16:17:03 | ||
| 2 | Update | 2014/08/05 14:39:00 | Recruitment status |
|
| 3 | Update | 2015/01/13 20:34:48 | Recruitment status |
|
| 4 | Update | 2019/01/18 16:47:34 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Results |
